Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 06:10 ET | Source: Research and Markets

CD40 Targeted Therapies Opportunity Insights Report 2026-2027: Market is Emerging with Over 35 Therapies in Trials and is Driven by Technological Innovations and Global Collaborations

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches, Proprietary Technology Platforms & Market Opportunity Insight 2026" report has...
October 14, 2025 07:30 ET | Source: Aanastra Inc

Aanastra Inc Announces Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 Mutations in Tumors (AAN-53x)

Aanastra Inc to present preclinical data for in vivo CAR-T and p53 RNA programs leveraging its proprietary PEP-NP™ peptide delivery technology
September 03, 2024 09:39 ET | Source: Research and Markets

gRNA Industry Research Report 2024: Size, Share, Trends, Opportunities, and Forecasts, 2019-2029F

Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "gRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's...
August 15, 2024 09:57 ET | Source: Research and Markets

CRISPR Gene Editing Market Size Projected to Surpass $2 Billion by 2024 Amid Increasing Demand for Genetic Treatments - Long-term Forecast to 2028 and 2033

Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Global CRISPR Gene Editing Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The CRISPR gene editing market has...
August 06, 2024 09:08 ET | Source: Research and Markets

CRISPR Technology Research Report 2024 | Now Available

Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "CRISPR Technology Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The crispr technology market size has grown...
November 02, 2023 08:00 ET | Source: Ractigen Therapeutics

Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting

Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
July 13, 2023 04:00 ET | Source: SiSaf Ltd

SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer

GUILDFORD, England, July 13, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd announces that it has appointed Nikos Tzagkarakis in the newly created role of Chief A.I....
April 05, 2023 03:00 ET | Source: SiSaf Ltd

SiSaf Appoints Dr. Richard Goodfellow to Board of Directors

GUILDFORD, England, April 05, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd today announced that it has appointed Dr. Richard Goodfellow to its Board of Directors. ...
October 10, 2022 08:03 ET | Source: Research and Markets

Advancements in miRNA Report 2022: Development of POC Diagnostics to Detect Circulating Biomarkers Across Diseases

Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Advancements in miRNA: Technology Assessment" report has been added to ResearchAndMarkets.com's offering. Accelerated research around RNA-based...
April 19, 2022 04:08 ET | Source: Research and Markets

Global CRISPR Technology Market Analysis 2022-2026, Featuring Profiles of Thermo Fisher Scientific, CRISPR Therapeutics, GenScript Biotech, Editas Medicine and Intellia Therapeutics

Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Technology Global Market Report 2022, By Product Type, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering....